Puma Biotechnology Inc - Company Profile
Powered by
All the data and insights you need on Puma Biotechnology Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Puma Biotechnology Inc Strategy Report
- Understand Puma Biotechnology Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Puma Biotechnology Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
20 Sep 2022 | Puma Biotech Enters into Licensing Agreement with Takeda Pharma | Licensing Agreement |
Puma Biotechnology Inc
|
Takeda Pharmaceutical Co Ltd |
10 Mar 2022 | Puma Biotech to Raise USD10 Million in Private Placement of Shares | Equity Offering |
Alan H Auerbach
|
Puma Biotechnology Inc |
18 Oct 2021 | Celcuity Enters into Clinical Trial Agreement with University of Rochester Medical Center and Puma Biotech | Partnership | - |
Celcuity Inc
University of Rochester Medical Center
Puma Biotechnology Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer